A new formulation of the COMIRNATY booster "12 years of age and older, Ready
to use (Original/Omicron BA.1 Cap and Package, Multi-dose vial)" was approved
on DD/MM/YY with procedure X/0000.Additional website content relevant to this
new formulation will be available on DD/MM/YY.
COMIRNATY Original/Omicron BA.1 15/15 micrograms/per dose for dispersion
for injection, for 12 years of age and older, Ready to use (Original/Omicron BA.1
Cap and Package, Multi-dose vial)
PP-CMR-GLB-0188
This site is intended for Healthcare Professionals in Iraq.
Home
Expiry Date Information
Report an Adverse Event
EUA Fact Sheets for Vaccination Providers
EUA Fact Sheets for Recipients
Resources
Medical Information
Visit: https://www.pmi-covid.com/en-afme/covid-19-mrna-vaccine-bnt162
The Pfizer-BioNTech COVID-19 Vaccine, which is based on
BioNTech proprietary mRNA technology, was developed
by both BioNTech and Pfizer.
This site is intended for Healthcare Professionals in Lebanon. The products discussed in the site may have different product labeling in different countries. The information provided is for educational purposes only.
This site is intended for Healthcare Professionals in Iraq. The products discussed in the site may have different product labeling in different countries. The information provided is for educational purposes only.